BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10550751)

  • 1. Cytokine profile of a long-term pediatric HIV survivor with hyper-IgE syndrome and a normal CD4 T-cell count.
    Seroogy CM; Wara DW; Bluth MH; Dorenbaum A; White C; Durkin HG; Elder ME
    J Allergy Clin Immunol; 1999 Nov; 104(5):1045-51. PubMed ID: 10550751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in vitro.
    Pellegrino MG; Bluth MH; Smith-Norowitz T; Fikrig S; Volsky DJ; Moallem H; Auci DL; Nowakowski M; Durkin HG
    AIDS Res Hum Retroviruses; 2002 Mar; 18(5):363-72. PubMed ID: 11897038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No indication for a defect in toll-like receptor signaling in patients with hyper-IgE syndrome.
    Renner ED; Pawlita I; Hoffmann F; Hornung V; Hartl D; Albert M; Jansson A; Endres S; Hartmann G; Belohradsky BH; Rothenfusser S
    J Clin Immunol; 2005 Jul; 25(4):321-8. PubMed ID: 16133988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome.
    Becker KL; Rösler B; Wang X; Lachmandas E; Kamsteeg M; Jacobs CW; Joosten LA; Netea MG; van de Veerdonk FL
    Clin Exp Allergy; 2016 Dec; 46(12):1564-1574. PubMed ID: 27474157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS.
    Paganelli R; Scala E; Mezzaroma I; Pinter E; D'Offizi G; Fanales-Belasio E; Rosso RM; Ansotegui IJ; Pandolfi F; Aiuti F
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):995-1003. PubMed ID: 7751521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Manifestation of hyper-IgE syndrome in advanced HIV-1 infection].
    Lange CG; Gripshover BM; Valdez H; Lederman MM
    Med Klin (Munich); 2002 Jan; 97(1):34-9. PubMed ID: 11831060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE against HIV proteins in clinically healthy children with HIV disease.
    Secord EA; Kleiner GI; Auci DL; Smith-Norowitz T; Chice S; Finkielstein A; Nowakowski M; Fikrig S; Durkin HG
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):979-84. PubMed ID: 8939162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donors.
    Wilson AD; Hopkins JC; Morgan AJ
    Clin Exp Immunol; 2001 Oct; 126(1):101-10. PubMed ID: 11678905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
    Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased type 2 cytokine expression by both CD4+ CD45RO+ T cells and CD8+ CD45RO+ T cells in blood circulation is associated with high serum IgE but not with atopic dermatitis.
    Sato A; Tsuji K; Yamamura M; Morita Y; Kanzaki H; Tada J; Makino H; Arata J
    J Invest Dermatol; 1998 Dec; 111(6):1079-84. PubMed ID: 9856820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection.
    Maggi E; Giudizi MG; Biagiotti R; Annunziato F; Manetti R; Piccinni MP; Parronchi P; Sampognaro S; Giannarini L; Zuccati G; Romagnani S
    J Exp Med; 1994 Aug; 180(2):489-95. PubMed ID: 8046328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood cell-specific cytokines in persons with untreated HIV infection in Malawi, Africa.
    Chatt JA; Jason J; Nwanyanwu OC; Archibald LK; Parekh B; Kazembe PN; Dobbie H; Jarvis WR
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1367-77. PubMed ID: 12487808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term resistance to HIV infection in vertical HIV infection: cytokine production, HIV isolation, and HIV phenotype define long-term resistant hosts.
    Vigano A; Balotta C; Trabattoni D; Bricalli D; Crupi L; Palomba E; Galli L; Salvaggio A; Fusi ML; Ruzzante S; Massironi E; Colombo MC; Principi N; Galli M; Clerici M
    Pathobiology; 1997; 65(4):169-76. PubMed ID: 9396039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.
    Becker Y
    Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte membrane antigen expression and intracellular cytokine patterns in an asymptomatic patient with persistently high serum levels of IgE.
    Krampera M; Antico A; Vinante F; Morosato L; Pizzolo G
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):144-8. PubMed ID: 10480588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of immunoglobulin production in hyper-IgE (Job's) syndrome.
    Garraud O; Mollis SN; Holland SM; Sneller MC; Malech HL; Gallin JI; Nutman TB
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):333-40. PubMed ID: 9949327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.
    Ngo-Giang-Huong N; Candotti D; Goubar A; Autran B; Maynart M; Sicard D; Clauvel JP; Agut H; Costagliola D; Rouzioux C;
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1435-46. PubMed ID: 11679156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infection.
    Herasimtschuk A; Downey J; Nelson M; Moyle G; Mandalia S; Sikut R; Adojaan M; Stanescu I; Gotch F; Imami N
    Vaccine; 2014 Dec; 32(51):7005-7013. PubMed ID: 25454870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.